Cargando…

Current status of use of big data and artificial intelligence in RMDs: a systematic literature review informing EULAR recommendations

OBJECTIVE: To assess the current use of big data and artificial intelligence (AI) in the field of rheumatic and musculoskeletal diseases (RMDs). METHODS: A systematic literature review was performed in PubMed MEDLINE in November 2018, with key words referring to big data, AI and RMDs. All original r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kedra, Joanna, Radstake, Timothy, Pandit, Aridaman, Baraliakos, Xenofon, Berenbaum, Francis, Finckh, Axel, Fautrel, Bruno, Stamm, Tanja A, Gomez-Cabrero, David, Pristipino, Christian, Choquet, Remy, Servy, Hervé, Stones, Simon, Burmester, Gerd, Gossec, Laure
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668041/ https://www.ncbi.nlm.nih.gov/pubmed/31413871 http://dx.doi.org/10.1136/rmdopen-2019-001004

Ejemplares similares

Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs
por: Gwinnutt, James M, et al.
Publicado: (2022)

Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs
por: Wieczorek, Maud, et al.
Publicado: (2022)

Smart battles: immunosuppression versus immunomodulation in the inflammatory RMDs
por: Isaacs, John D, et al.
Publicado: (2020)

EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs
por: Bijlsma, Johannes WJ
Publicado: (2021)

Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs
por: Gwinnutt, James M, et al.
Publicado: (2022)

EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases
por: Najm, Aurélie, et al.
Publicado: (2019)

Analysing and reporting of observational data: a systematic review informing the EULAR points to consider when analysing and reporting comparative effectiveness research with observational data in rheumatology
por: Lauper, Kim, et al.
Publicado: (2021)

Big data analyses and individual health profiling in the arena of rheumatic and musculoskeletal diseases (RMDs)
por: De Cock, Diederik, et al.
Publicado: (2022)

Characterisation of prodromal and very early psoriatic arthritis: a systematic literature review informing a EULAR taskforce
por: De Marco, Gabriele, et al.
Publicado: (2023)

EULAR ‘points to consider’ for the conduction of workforce requirement studies in rheumatology
por: Dejaco, Christian, et al.
Publicado: (2018)

EULAR points to consider for including the perspective of young patients with inflammatory arthritis into patient-reported outcomes measures
por: Studenic, Paul, et al.
Publicado: (2022)

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
por: Gossec, Laure, et al.
Publicado: (2020)

Nutrition in RMDs: is it really food for thought? Focus on rheumatoid arthritis
por: Alunno, Alessia, et al.
Publicado: (2020)

Implementation and role of modern musculoskeletal imaging in rheumatological practice in member countries of EULAR
por: Mandl, Peter, et al.
Publicado: (2019)

EULAR recommendations for intra-articular therapies
por: Uson, Jacqueline, et al.
Publicado: (2021)

Young people’s perspectives on patient-reported outcome measures in inflammatory arthritis: results of a multicentre European qualitative study from a EULAR task force
por: Mosor, Erika, et al.
Publicado: (2021)

Value of imaging to guide interventional procedures in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
por: Bosch, Philipp, et al.
Publicado: (2021)

RegEnrich gene regulator enrichment analysis reveals a key role of the ETS transcription factor family in interferon signaling
por: Tao, Weiyang, et al.
Publicado: (2022)

Integration of Immunome With Disease-Gene Network Reveals Common Cellular Mechanisms Between IMIDs and Drug Repurposing Strategies
por: Devaprasad, Abhinandan, et al.
Publicado: (2021)

Physical Activity Assessment Using an Activity Tracker in Patients with Rheumatoid Arthritis and Axial Spondyloarthritis: Prospective Observational Study
por: Jacquemin, Charlotte, et al.
Publicado: (2018)

Workforce requirements in rheumatology: a systematic literature review informing the development of a workforce prediction risk of bias tool and the EULAR points to consider
por: Unger, Julia, et al.
Publicado: (2018)

Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis
por: Sepriano, Alexandre, et al.
Publicado: (2017)

EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19
por: Alunno, Alessia, et al.
Publicado: (2021)

EMerging EULAR NETwork (EMEUNET): a remarkable foundation for the future
por: Alunno, Alessia, et al.
Publicado: (2021)

Exploring discordance between Health Literacy Questionnaire scores of people with RMDs and assessment by treating health professionals
por: Bakker, Mark M, et al.
Publicado: (2022)

Wearable Activity Trackers in the Management of Rheumatic Diseases: Where Are We in 2020?
por: Davergne, Thomas, et al.
Publicado: (2020)

Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis
por: Regel, Andrea, et al.
Publicado: (2017)

Flares assessed weekly in patients with rheumatoid arthritis or axial spondyloarthritis and relationship with physical activity measured using a connected activity tracker: a 3-month study
por: Jacquemin, Charlotte, et al.
Publicado: (2017)

The Impact of Fibromyalgia in Spondyloarthritis: From Classification Criteria to Outcome Measures
por: Alunno, Alessia, et al.
Publicado: (2018)

2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations
por: van der Heijde, Désirée, et al.
Publicado: (2015)

EULAR portfolio for Rheumatology training: a EULAR School of Rheumatology initiative
por: van Onna, Marloes, et al.
Publicado: (2021)

NET-RMDs study: networks of fatigue and pain in rheumatic and musculoskeletal diseases – protocol for an international cross-sectional study
por: Gavilán-Carrera, Blanca, et al.
Publicado: (2022)

EULAR Kongress-Splitter
por: Bach, Bianca
Publicado: (2021)

Rheumatology 4.0: big data, wearables and diagnosis by computer
por: Burmester, Gerd R
Publicado: (2018)

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
por: Smolen, Josef S, et al.
Publicado: (2010)

Initial validation and results of the Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: a EULAR project
por: van Beers-Tas, Marian H, et al.
Publicado: (2018)

Performance of the new 2011 ACR/EULAR remission criteria with tocilizumab using the phase IIIb study TAMARA as an example and their comparison with traditional remission criteria
por: Iking-Konert, Christof, et al.
Publicado: (2011)

Non-pharmacological interventions to promote work participation in people with rheumatic and musculoskeletal diseases: a systematic review and meta-analysis from the EULAR taskforce on healthy and sustainable work participation
por: Butink, Maarten H P, et al.
Publicado: (2023)

EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors
por: Kostine, Marie, et al.
Publicado: (2021)

Eular Textbook on Rheumatic Diseases
por: Adwan, Marwan H.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_uempd2cqf409h906htbs5hn4o4